Balance of the prooxidant and antioxidant system is associated with mortality in critically ill patients.

biological antioxidant potential critically ill patients modified ratio mortality oxidative stress

Journal

Journal of clinical biochemistry and nutrition
ISSN: 0912-0009
Titre abrégé: J Clin Biochem Nutr
Pays: Japan
ID NLM: 8700907

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 23 07 2022
accepted: 06 11 2022
entrez: 20 3 2023
pubmed: 21 3 2023
medline: 21 3 2023
Statut: ppublish

Résumé

It is well known that oxidative stress causes certain diseases and organ damage. However, roles of oxidative stress in the acute phase of critical patients remain to be elucidated. This study aimed to investigate the balance of oxidative and antioxidative system and to clarify the association between oxidative stress and mortality in critically ill patients. This cohort study enrolled 247 patients transported to our emergency department by ambulance. Blood was drawn on hospital arrival, and serum derivatives of reactive oxidant metabolites (dROMs, oxidative index) and biological antioxidant potential (BAP, antioxidative index) were measured. Modified ratio (MR) is also calculated as BAP/dROMs/7.51. There were 197 survivors and 50 non-survivors. In the non-survivors, dROMs were significantly lower (274 vs 311,

Identifiants

pubmed: 36936878
doi: 10.3164/jcbn.22-79
pii: DN/JST.JSTAGE/jcbn/22-79
pmc: PMC10017322
doi:

Types de publication

Journal Article

Langues

eng

Pagination

157-164

Informations de copyright

Copyright © 2023 JCBN.

Déclaration de conflit d'intérêts

No potential conflicts of interest were disclosed.

Références

Oxid Med Cell Longev. 2022 Feb 18;2022:2097318
pubmed: 35222792
Free Radic Biol Med. 2006 Feb 1;40(3):398-406
pubmed: 16443154
J Nutr. 2001 Dec;131(12):3208-11
pubmed: 11739867
Vasc Health Risk Manag. 2011;7:475-82
pubmed: 21822395
Br Med Bull. 1999;55(1):49-75
pubmed: 10695079
Crit Care. 2006 Feb;10(1):R36
pubmed: 16507162
Ann Intensive Care. 2016 Dec;6(1):39
pubmed: 27107565
J Crit Care. 2015 Feb;30(1):217.e7-12
pubmed: 25307978
Panminerva Med. 2002 Mar;44(1):37-40
pubmed: 11887090
Am J Emerg Med. 2021 Jul;45:264-268
pubmed: 33046299
Eur J Haematol. 2017 Oct;99(4):306-314
pubmed: 28646624
Front Physiol. 2020 Jul 02;11:694
pubmed: 32714204
Oxid Med Cell Longev. 2013;2013:562429
pubmed: 24066191
Clin Exp Nephrol. 2007 Sep;11(3):218-224
pubmed: 17891349
Vet Res Commun. 2008 Feb;32(2):137-43
pubmed: 17846911
J Clin Biochem Nutr. 2020 Sep;67(2):214-221
pubmed: 33041520
J Am Heart Assoc. 2015 Jan 28;4(2):
pubmed: 25630910
Acta Med Okayama. 2010 Oct;64(5):323-30
pubmed: 20975766
Int Angiol. 1999 Jun;18(2):127-30
pubmed: 10424368
BMC Neurol. 2015 Jul 25;15:115
pubmed: 26205136
Crit Care Med. 2000 Jun;28(6):1812-4
pubmed: 10890625
Am J Case Rep. 2015 Apr 30;16:255-8
pubmed: 25925532
Int J Clin Pharmacol Res. 2001;21(2):79-84
pubmed: 11824651
Antioxid Redox Signal. 2007 Feb;9(2):281-7
pubmed: 17115943
Int J Mol Sci. 2013 Mar 18;14(3):6106-15
pubmed: 23507749
Sports Med. 2006;36(4):327-58
pubmed: 16573358
J Crit Care. 2018 Oct;47:139-144
pubmed: 29981999
Hypertens Res. 2011 Sep;34(9):1041-5
pubmed: 21677660

Auteurs

Hiroo Izumino (H)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.
Acute and Critical Care Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Goro Tajima (G)

Acute and Critical Care Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Department of Emergency Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Osamu Tasaki (O)

Acute and Critical Care Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.
Department of Emergency Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Takamitsu Inokuma (T)

Acute and Critical Care Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Go Hatachi (G)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Katsunori Takagi (K)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Takuro Miyazaki (T)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Keitaro Matsumoto (K)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Tomoshi Tsuchiya (T)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Shuntaro Sato (S)

Clinical Research Center, Nagasaki University Hospital, 1-7-1 Sakamoto, Nagasaki 852-8501, Japan.

Takeshi Nagayasu (T)

Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan.

Classifications MeSH